Meritage Homes
MTH
KB Home
KBH
D.R. Horton
DHI
4
Adobe
ADBE
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
ALLO Allogene Therapeutics
- 1.680
- +0.140+9.09%
Close Apr 30 16:00 ET
- 1.700
- +0.020+1.19%
Post 20:01 ET
365.00MMarket Cap-1.27P/E (TTM)
1.700High1.510Low6.05MVolume1.530Open1.540Pre Close9.71MTurnover3.87%Turnover RatioLossP/E (Static)217.26MShares3.78052wk High0.86P/B262.67MFloat Cap1.23052wk Low--Dividend TTM156.35MShs Float55.000Historical High--Div YieldTTM12.34%Amplitude1.230Historical Low1.605Avg Price1Lot Size
Allogene Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -76.84%22K | 0 | 0 | 0 | -26.67%22K | -39.10%95K | 152.50%21K | -55.10%22K | -74.42%22K | -50.82%30K |
| Operating revenue | -76.84%22K | --0 | --0 | --0 | -26.67%22K | -39.10%95K | 152.50%21K | -55.10%22K | -74.42%22K | -50.82%30K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -18.15%257.5M | -15.85%60.49M | -3.13%61.05M | -17.53%66.44M | -29.86%69.53M | -6.29%314.59M | -25.45%71.89M | -23.65%63.02M | 5.06%80.56M | 23.82%99.12M |
| Selling and administrative expenses | -9.02%65.21M | -9.90%15.52M | -4.15%16.33M | -13.16%16.09M | -8.56%17.27M | -9.62%71.67M | -17.99%17.22M | -9.82%17.04M | -5.05%18.52M | -5.09%18.88M |
| -General and administrative expense | -9.02%65.21M | -9.90%15.52M | -4.15%16.33M | -13.16%16.09M | -8.56%17.27M | -9.62%71.67M | -17.99%17.22M | -9.82%17.04M | -5.05%18.52M | -5.09%18.88M |
| Research and development costs | -20.84%192.3M | -17.73%44.97M | -2.75%44.71M | -18.83%50.36M | -34.87%52.26M | -5.25%242.91M | -27.52%54.66M | -27.76%45.98M | 8.51%62.04M | 33.38%80.24M |
| Operating profit | 18.13%-257.48M | 15.83%-60.49M | 3.10%-61.05M | 17.50%-66.44M | 29.86%-69.5M | 6.27%-314.49M | 25.50%-71.86M | 23.63%-63M | -5.15%-80.54M | -23.88%-99.09M |
| Net non-operating interest income expense | 9.09%19.97M | -52.98%2.95M | 6.45%6.61M | 32.03%4.99M | 163.87%5.43M | 300.94%18.31M | 127.24%6.27M | 519.26%6.21M | 1,099.37%3.78M | 318.50%2.06M |
| Non-operating interest income | 10.08%20.15M | -51.68%3.03M | 8.06%6.71M | 32.03%4.99M | 163.87%5.43M | 300.94%18.31M | 127.24%6.27M | 519.26%6.21M | 1,099.37%3.78M | 318.50%2.06M |
| Non-operating interest expense | --181K | --81K | --100K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other net income (expense) | 36.82%-19.64M | 90.33%-1.95M | -115.65%-11.85M | -98.54%-4.9M | 68.35%-929K | -229.10%-31.08M | -126.10%-20.18M | -230.89%-5.5M | -265.55%-2.47M | -738.57%-2.94M |
| Special income (charges) | -18.66%-15.72M | --0 | ---10.73M | ---4.99M | ---- | ---13.25M | ---13.25M | --0 | --0 | ---- |
| -Less:Impairment of capital assets | 18.66%15.72M | --0 | --10.73M | --4.99M | ---- | --13.25M | --13.25M | --0 | --0 | ---- |
| Other non- operating income (expenses) | 78.02%-3.92M | 71.85%-1.95M | 79.55%-1.12M | 103.44%85K | 68.35%-929K | -88.85%-17.84M | 22.31%-6.93M | -230.89%-5.5M | -265.55%-2.47M | -738.57%-2.94M |
| Income before tax | 21.43%-257.15M | 30.64%-59.5M | -6.43%-66.29M | 16.25%-66.36M | 34.98%-65M | 3.86%-327.27M | 16.42%-85.78M | 25.09%-62.29M | -5.94%-79.23M | -25.19%-99.97M |
| Income tax | 443K | 0 | ||||||||
| Net income | 21.29%-257.59M | 30.12%-59.94M | -6.43%-66.29M | 16.25%-66.36M | 34.98%-65M | 3.86%-327.27M | 16.42%-85.78M | 25.09%-62.29M | -5.94%-79.23M | -25.19%-99.97M |
| Net income continuous Operations | 21.29%-257.59M | 30.12%-59.94M | -6.43%-66.29M | 16.25%-66.36M | 34.98%-65M | 3.86%-327.27M | 16.42%-85.78M | 25.09%-62.29M | -5.94%-79.23M | -25.19%-99.97M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 21.29%-257.59M | 30.12%-59.94M | -6.43%-66.29M | 16.25%-66.36M | 34.98%-65M | 3.86%-327.27M | 16.42%-85.78M | 25.09%-62.29M | -5.94%-79.23M | -25.19%-99.97M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 21.29%-257.59M | 30.12%-59.94M | -6.43%-66.29M | 16.25%-66.36M | 34.98%-65M | 3.86%-327.27M | 16.42%-85.78M | 25.09%-62.29M | -5.94%-79.23M | -25.19%-99.97M |
| Basic earnings per share | 36.84%-1.32 | 45.10%-0.28 | 13.51%-0.32 | 35.19%-0.35 | 44.93%-0.38 | 12.18%-2.09 | 22.73%-0.51 | 36.21%-0.37 | -3.85%-0.54 | -23.21%-0.69 |
| Diluted earnings per share | 36.84%-1.32 | 45.10%-0.28 | 13.51%-0.32 | 35.19%-0.35 | 44.93%-0.38 | 12.18%-2.09 | 22.73%-0.51 | 36.21%-0.37 | -3.85%-0.54 | -23.21%-0.69 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025